NAD ⁺ homeostasis in human health and disease

Abstract

Depletion of nicotinamide adenine dinucleotide (NAD ⁺), a central redox cofactor and the substrate of key metabolic enzymes, is the causative factor of a number of inherited and acquired diseases in humans. Primary deficiencies of NAD ⁺ homeostasis are the result of impaired biosynthesis, while secondary deficiencies can arise due to other factors affecting NAD ⁺ homeostasis, such as increased NAD ⁺ consumption or dietary deficiency of its vitamin B3 precursors. NAD ⁺ depletion can manifest in a wide variety of pathological phenotypes, ranging from rare inherited defects, characterized by congenital malformations, retinal degeneration, and/or encephalopathy, to more common multifactorial, often age‐related, diseases. Here, we discuss NAD ⁺ biochemistry and metabolism and provide an overview of the etiology and pathological consequences of alterations of the NAD ⁺ metabolism in humans. Finally, we discuss the state of the art of the potential therapeutic implications of NAD ⁺ repletion for boosting health as well as treating rare and common diseases, and the possibilities to achieve this by means of the different NAD ⁺‐enhancing agents.

Abstract

This comprehensive review discusses pathological consequences of NAD ⁺ metabolism alterations and the therapeutic potential of NAD ⁺ enhancers.